Home/Filings/4/0001104659-25-070027
4//SEC Filing

Saggar Rajeev 4

Accession 0001104659-25-070027

CIK 0001819576other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 4:30 PM ET

Size

5.5 KB

Accession

0001104659-25-070027

Insider Transaction Report

Form 4
Period: 2025-07-21
Saggar Rajeev
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-07-21$14.54/sh2,526$36,728268,887 total
Footnotes (3)
  • [F1]Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
  • [F2]These shares were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022.
  • [F3]Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Issuer

Liquidia Corp

CIK 0001819576

Entity typeother

Related Parties

1
  • filerCIK 0001935638

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:30 PM ET
Size
5.5 KB